Get started
Author

Likun Chen

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
2018 · Wenfeng Fang, Yunpeng Yang, et al. · The Lancet Oncology · 514
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
2024 · HARMONi-A Study Investigators, Wenfeng Fang, et al. · JAMA · 259
PDF
RETRACTED ARTICLE: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1
2019 · Hongsheng Wang, Qianqian Deng, et al. · Molecular Cancer · 218
Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
2019 · Hongsheng Wang, Qiuxiang Ou, et al. · Cancer · 125
PDF
RNA m 1 A methylation regulates glycolysis of cancer cells through modulating ATP5D
2022 · Yingmin Wu, Zhuojia Chen, et al. · Proceedings of the National Academy of Sciences · 117
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China
2012 · Cong Xue, Zhihuang Hu, et al. · Lung Cancer · 114
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2023 · Xiaomin Zhang, Limin Cheng, et al. · Cancer Research · 96
PDF
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance
2019 · Xiaokun Wang, Dongjuan Qiao, et al. · Molecular Cancer · 86
PDF
GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells
2018 · Qianqian Deng, Guanmin Jiang, et al. · Journal of Hazardous Materials · 83
N6 -Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer
2023 · Haisheng Zhang, Jiawang Zhou, et al. · Cancer Research · 66
Gefitinib Plus Chemotherapy Versus Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer Patients with Brain Metastases (GAP BRAIN): An Open-Label, Randomized, Multicenter, Phase 3 Study
2022 · Xue Hou, Meichen Li, et al. · JAMA Network Open · 61
PDF
Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study
2023 · Xue Hou, Chengzhi Zhou, et al. · Journal of Thoracic Oncology · 58
PDF
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo , and Ex Vivo
2016 · Zhen Chen, Yifan Chen, et al. · Molecular Cancer Therapeutics · 54
PDF
Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer
2018 · Yan Zhou, Linlin Lu, et al. · Cell Death and Differentiation · 51
PDF
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target
2024 · Hao Duan, Jianlan Ren, et al. · Genome Medicine · 48
PDF
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib
2019 · Jun Zhao, Gen Lin, et al. · Lung Cancer · 45
Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
2017 · Ke Yang, Yifan Chen, et al. · Experimental & Molecular Medicine · 45
PDF
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
2022 · Meichen Li, Jing Chen, et al. · BMC Medicine · 40
PDF
RETRACTED ARTICLE: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
2018 · Xue Hou, Run Gong, et al. · BMC Cancer · 36
PDF
Prevalence of Burnout and Career Satisfaction Among Oncologists in China: A National Survey
2018 · Shuxiang Ma, Yan Huang, et al. · The Oncologist · 35
The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
2018 · Shu-Xiang Ma, Ting Zhou, et al. · Annals of Translational Medicine · 34
Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy
2016 · Zhihuang Hu, Wenhua Liang, et al. · Medicine · 34
A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours
2011 · Xuexin He, Su Li, et al. · British Journal of Clinical Pharmacology · 34
PDF
Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study
2008 · Likun Chen, Youjian He, et al. · Medical Oncology · 33
Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort study
2022 · Xinqing Lin, Haiyi Deng, et al. · Translational Lung Cancer Research · 32
PDF
Works count: 187
Citation count: 3,149
H-index: 29
I10-index: 59
Year
Topic
Type